Among those, receptor tyrosine kinases (EGFR, FGFR, and VEGFR) signaling through Ras-MAPK or Ras-PI3K-Akt axes are the most frequently hyperactive pathways implicated in bladder cancer progression [25–27]. The gene discussed is AKT1; the disease is urinary bladder cancer.